1-8 of 8
Xiaoqin Chen
Close
Sort by
Journal Articles

Real-World Outcome of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma: A Multicenter Propensity Score Matched Case Series Study

Weida Wang, Yaofang Hu, Yun Wang, Xiaoqin Chen, Zhongjun Xia
Journal: Blood
Blood (2022) 140 (Supplement 1): 12589–12590.
https://doi.org/10.1182/blood-2022-171132
Published: 2022
Journal Articles

Identification of a Novel Drug Sensitivity Biomarker Neuregulin-2 for Venetoclax in Non-t(11;14) Multiple Myeloma

Yujun Dai, Xue-Ping Li, Fang Hu, Jinyuan Li, Yang Liang, Da-Wei Wang, Zhongjun Xia, Xiaoqin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 459.
https://doi.org/10.1182/blood-2021-150370
Published: 2021
Journal Articles

Development and Validation of a Risk Assessment Model for Early Infection during the First 3 Months in Patients with Newly Diagnosed Multiple Myeloma

Yufeng Shang, Weida Wang, MD PhD, Minghui Liu, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Fuling Zhou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141735
Published: 2020
Journal Articles

The Expression of Paks and Its Clinical Significance in T-Cell Lymphoblastic Lymphoma

Qingqing Cai, PhD, Ning Su, MM, Yu Fang, BMBS, Xu Chen, MDPhD, Xiaopeng Tian, MDPhD, Shuyun Ma, MM, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Tongyu Lin, MD PhD, Huiqiang Huang, MDPhD, Zhiming Li, MD PhD, Xueyi Pan, MDPhD, Yi Xia, MD PhD, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Hang Yang, MD PhD, Stephen Yang Liang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
https://doi.org/10.1182/blood-2020-136975
Published: 2020
Journal Articles

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Zhongjun Xia, MDPhD, Su Li, Xiaoqin Chen, MDPhD, Weida Wang, MD PhD, Yan Song
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-137346
Published: 2020
Journal Articles

The Role of Interim F-18 FDG PET/CT in Patients of T Lymphoblastic Leukemia/Lymphoma Treated with ALL-Type Regimens

Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD, Wen Long, MD
Journal: Blood
Blood (2015) 126 (23): 5015.
https://doi.org/10.1182/blood.V126.23.5015.5015
Published: 2015
Journal Articles

Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma

Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD
Journal: Blood
Blood (2015) 126 (23): 5399.
https://doi.org/10.1182/blood.V126.23.5399.5399
Published: 2015
Journal Articles

Small Compound 6- O -Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potential In Multiple Myeloma

Ying Liu, Xiaoqin Chen, Yongxian Cheng, Guangbiao Zhou, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 5043.
https://doi.org/10.1182/blood.V116.21.5043.5043
Published: 2010